Responses
Poster Presentations
P04 Precision Medicine Meets Immunotherapy (Immuno-Monitoring)
P04.02 Diversity of CD4+ blood T-cell clonality predicts longer survival with CTLA4 or PD-1 checkpoint inhibition in advanced melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.